This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

RNA Leaders USA
New Data, Case Studies & Partners
September 4th-5th, 2024San Diego Convention Center, USA

Vasudev Bailey
Partner at ARTIS Ventures
Speaker

Profile

Vasudev Bailey invests in disruptive tech, consumer and healthcare (therapeutic, diagnostic, device, digital) companies as a Partner at ARTIS Ventures. He currently serves on the board of advisors at Excision Biosciences, EKO, Aether Biomachines and a board observer at IDbyDNA and TAE Life Sciences.

Previously, Vas worked in helping ARTIS’s portfolio company Quid on their , Vas co-founded and served as the General Manager of the GLG Institute. In this role, he worked with Jeff Kindler (former CEO Pfizer), David Brennan (former CEO AZ), Shlomo Yanai (former CEO Teva) and Neil Golden (former CMO McDonald’s) and built a forum to connect retired C-suite executives with exceptional aspiring leaders.

Vas continues to draw on his strategy consulting background at McKinsey & Company as well as his experience from several acquired startups. He currently serves as an advisor to four startups and serves on three boards.

Vas received his PhD in Biomedical Engineering from the Johns Hopkins School of Medicine where he was recognized as both a Siebel and a Medtronic Scholar. He holds four provisional patents from his research in nanotechnology for the early detection of cancer and has over thirty conference and journal publications. He graduated magna cum laude and Phi Beta Kappa from UC Irvine where he was also recognized as both a Regents and a Henry Samueli Scholar.

Agenda Sessions

  • RNA REVOLUTION: DECIPHERING THE INVESTMENT LANDSCAPE - MODALITY, TECHNOLOGY OR INDICATION?

    3:30pm

At this event